about
Venous thromboembolic diseasePrevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesVenous thromboembolism in cancer patients: an underestimated major health problemBiomolecular markers of cancer-associated thromboembolismVenous thromboembolism in the cancer population: pathology, risk, and preventionReal-Time Label-Free Embolus Detection Using In Vivo Photoacoustic Flow CytometryCancer-associated thrombosis.Venous access catheter-related thrombosis in patients with cancer.Antithrombotic therapy in patients with thrombocytopenic cancer: outcomes associated with reduced-dose, low-molecular-weight heparin during hospitalization.Venous thromboembolism in cancer patients.Long-term activation of the pro-coagulant response after neoadjuvant chemoradiation and major cancer surgeryThe potential benefits of low-molecular-weight heparins in cancer patientsCancer-associated thrombosis: an overviewThe Impact of Cancer on the Clinical Outcome of Patients After Inferior Vena Cava Filter Placement: A Retrospective Cohort Study.Mesenteric ischemia after capecitabine treatment in rectal cancer and resultant short bowel syndrome is not an absolute contraindication for radical oncological treatmentRisk factors and incidence of thromboembolic events (TEEs) in older men and women with breast cancerChemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study.Increased Levels of NF-kB-Dependent Markers in Cancer-Associated Deep Venous Thrombosis.High rates of venous thromboembolic events in patients undergoing systemic therapy for urothelial carcinoma: A systematic review and meta-analysis.Impact of venous thromboembolism on mortality of elderly Medicare patients with stage III colon cancerSevere hepatic dysfunction is associated with venous thromboembolic events in phase 1 clinical trials.Management of venous thromboembolism in patients with cancer: role of dalteparin.The prothrombotic activity of cancer cells in the circulationEpidemiology of cancer-related venous thromboembolism.The application of clinical variables and models to predict pulmonary embolism in cancer patients: a comprehensive single cancer center experienceVenous thromboembolism (VTE) in patients with cancer: epidemiology and risk factors.Management of venous thromboembolism and the potential to impact overall survival in patients with cancer.Peripheral arterial ischemic events in cancer patients.Venous thromboembolism in patients with cancer: an overview for pharmacists using a case-based approach.Thromboembolic disease in cancer patients.Thrombosis in pediatric cancer: identifying the risk factors to improve care.Low molecular weight heparin (LMWH) for primary thrombo-prophylaxis in patients with solid malignancies - systematic review and meta-analysis.Prevention and treatment of thrombosis associated with central venous catheters in cancer patients.Once daily versus twice daily enoxaparin for acute pulmonary embolism in cancer patients.Venous thromboembolism in cancer patients: risk assessment, prevention and management.Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study.Systematic review and meta-analysis of the risk of severe and life-threatening thromboembolism in cancer patients receiving anti-EGFR monoclonal antibodies (cetuximab or panitumumab).Evaluation of thromboembolic events in cancer patients receiving bevacizumab according to the Japanese Adverse Drug Event Report database.Identifying ischemic stroke associated with cancer: a multiple model derived from a case-control analysis.Time-dependent risk and predictors of venous thromboembolism in breast cancer patients: A population-based cohort study.
P2860
Q24631121-B6056825-8E1C-420A-914E-F07BB1C3BC8FQ24633010-52DEBCBB-F806-4878-AC03-0E26BBB84995Q26852015-D6A7F884-4004-4681-9D52-274590619986Q26865716-8D7E6B7A-5087-49DB-9D0C-D17DD13596DCQ26996508-44F8C650-0DA6-4B8B-8DCB-032D82B05401Q30381707-D88EFBAF-3A1C-4496-AAB7-BB9A7D6518D5Q33389006-4920F9A7-DA99-468E-B835-AB8245A08A72Q33408419-C2A3ED76-E0E2-4E1B-BECA-7DF607D9E988Q33416407-C6E62AA1-75F4-4663-8500-59B643319928Q33419213-7103BE21-876A-483F-8CAE-366DA40DF8E9Q33620158-F4A81DF3-0679-4539-8E58-FF003CD5648CQ33698360-C90BA43D-76BB-4639-AA5B-FD6C8E714E1BQ34655217-CA757B62-C370-4AC2-862D-4E70BAF0367EQ34785094-1BAB0A73-D41F-45C6-90F7-CEBC3816C424Q35297106-04171D77-91FD-460F-8CF1-B50CD6219808Q35432469-B03EDB03-7DA5-48F1-BFC0-D6D4EE88A864Q35563035-01B283CD-6198-49F6-A43E-A02C3E825766Q35699340-16D2A30D-14BD-4C51-B4DA-B946ED8AC9C4Q36042344-0ECF155C-4572-494F-9D89-EA7ED8245CADQ36251473-19BE359E-4C20-45B4-967A-BDBD8AAB720EQ36372550-ABD45506-63FC-4F14-9703-74BF189F072CQ36812767-69FB215E-731B-4405-9C1B-64E467DB1DC7Q37088087-FD19D7E8-C7F2-40FD-B8BD-DB2C9253BDE9Q37242472-5B67079B-C42C-4A19-85CF-662ED7B4E563Q37261341-B86929AD-9B38-41F9-BFBA-05488308BF5FQ37416512-AAFDAAFC-505B-4D5A-AC9F-5C80056D16F9Q37621554-FBBBCCA1-BFD4-44FF-95CA-A6928A80EABDQ37812994-E1BA3947-2D1E-4576-921F-384C762BDC55Q37867284-C0401EED-EE5F-4FC6-9BCD-5F69C0A1CA29Q38083556-33A27358-C96E-438D-9DD8-FA5E494261D9Q38152512-ED4ADB68-D45E-427D-97C1-7B6605E1C2EAQ38243883-0DBF57DC-5E46-4BCB-AE1B-277C924AF1F6Q38244947-96B84BC1-04B9-487D-919D-0C2F0002A7A7Q38427457-50CE84D5-BC4C-40FA-8FCE-6FDD3385FD15Q38751462-DF5B0469-C591-4422-A1F9-1D45907FC0AEQ38829676-7FA28F58-241E-4493-BBD9-4F81626ADD6EQ38906609-44AEE09F-7168-424A-B99E-891841D57A9BQ39179354-E56668B2-E7F4-4415-B759-2E17D2576BC5Q40313897-7F9D8421-1513-4D24-984F-9D4AC5A51AB1Q40546472-8C60DCDC-7B63-4431-BCFA-5F70F7065CB1
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Chemotherapy-induced thrombosis.
@ast
Chemotherapy-induced thrombosis.
@en
type
label
Chemotherapy-induced thrombosis.
@ast
Chemotherapy-induced thrombosis.
@en
prefLabel
Chemotherapy-induced thrombosis.
@ast
Chemotherapy-induced thrombosis.
@en
P1433
P1476
Chemotherapy-induced thrombosis.
@en
P2093
Edward W Greeno
Tufia C Haddad
P304
P356
10.1016/J.THROMRES.2005.10.015
P577
2006-01-04T00:00:00Z